{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T19:51:51Z","timestamp":1760385111854},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2011,2,8]],"date-time":"2011-02-08T00:00:00Z","timestamp":1297123200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1007\/s00213-011-2196-5","type":"journal-article","created":{"date-parts":[[2011,2,7]],"date-time":"2011-02-07T02:53:54Z","timestamp":1297047234000},"page":"441-454","source":"Crossref","is-referenced-by-count":15,"title":["Prepulse inhibition of the startle reflex and response to antipsychotic treatments in two outbred mouse strains in comparison to the inbred DBA\/2 mouse"],"prefix":"10.1007","volume":"215","author":[{"given":"Dorothy G.","family":"Flood","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Zuvich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J.","family":"Marino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maciej","family":"Gasior","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,2,8]]},"reference":[{"key":"2196_CR1","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0091-3057(97)00421-8","volume":"59","author":"JK Belknap","year":"1998","unstructured":"Belknap JK, Riggan J, Cross S, Young ER, Gallaher EJ, Crabbe JC (1998) Genetic determinants of morphine activity and thermal responses in 15 inbred mouse strains. Pharmacol Biochem Behav 59:353\u2013360","journal-title":"Pharmacol Biochem Behav"},{"key":"2196_CR2","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s00213-007-0845-5","volume":"194","author":"M Bortolato","year":"2007","unstructured":"Bortolato M, Frau R, Orr\u00f9 M, Piras AP, F\u00e0 M, Tuveri A, Puligheddu M, Gessa GL, Castelli MP, Mereu G, Marrosu F (2007) Activation of GABAB receptors reverses spontaneous gating deficits in juvenile DBA\/2J mice. Psychopharmacology 194:361\u2013369","journal-title":"Psychopharmacology"},{"key":"2196_CR3","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.pbb.2008.06.009","volume":"91","author":"D Boulay","year":"2008","unstructured":"Boulay D, Pichat P, Dargazanli G, Estenne-Bouhtou G, Terranova JP, Rogacki N, Stemmelin J, Coste A, Lanneau C, Desvignes C, Cohen C, Alonso R, Vig\u00e9 X, Biton B, Steinberg R, Sevrin M, Oury-Donat F, George P, Bergis O, Griebel G, Avenet P, Scatton B (2008) Characterization of SSR103800, a selective inhibitor of the glycine transporter-1 in models predictive of therapeutic activity in schizophrenia. Pharmacol Biochem Behav 91:47\u201358","journal-title":"Pharmacol Biochem Behav"},{"key":"2196_CR4","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/s002130100810","volume":"156","author":"DL Braff","year":"2001","unstructured":"Braff DL, Geyer MA, Swerdlow NR (2001) Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies. Psychopharmacology 156:234\u2013258","journal-title":"Psychopharmacology"},{"key":"2196_CR5","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.bbr.2003.11.001","volume":"153","author":"KE Browman","year":"2004","unstructured":"Browman KE, Komater VA, Curzon P, Rueter LE, Hancock AA, Decker MW, Fox GB (2004) Enhancement of prepulse inhibition of startle in mice by the H3 receptor antagonists thioperamide and ciproxifan. Behav Brain Res 153:69\u201376","journal-title":"Behav Brain Res"},{"key":"2196_CR6","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s00213-010-1863-2","volume":"210","author":"A Burban","year":"2010","unstructured":"Burban A, Sadakhom C, Dumoulin D, Rose C, Le Pen G, Frances H, Arrang J-M (2010) Modulation of prepulse inhibition and stereotypies in rodents: no evidence for antipsychotic-like properties of histamine H3-receptor inverse agonists. Psychopharmacology 210:591\u2013604","journal-title":"Psychopharmacology"},{"key":"2196_CR7","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0278-5846(97)00184-X","volume":"22","author":"P Curzon","year":"1998","unstructured":"Curzon P, Decker MW (1998) Effects of phencyclidine (PCP) and (+)MK-801 on sensorimotor gating in CD-1 mice. Prog Neuropsychopharmacol Biol Psychiatry 22:129\u2013146","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"2196_CR8","unstructured":"Dargazanli G, Estenne-Bouhtou G, Magat P, Marabout B, Medaisko F, Roger P, Sevrin M, Veronique C (2003) Derivatives of N-[phenyl(piperidin-2-yl)methyl]benzamide, the preparation method thereof and application of same in therapeutics. World Patent WO2003089411, 2003 30 Oct"},{"key":"2196_CR9","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1038\/sj.npp.1300772","volume":"30","author":"R Depoort\u00e8re","year":"2005","unstructured":"Depoort\u00e8re R, Dargazanli G, Estenne-Bouhtou G, Coste A, Lanneau C, Desvignes C, Poncelet M, Heaulme M, Santucci V, Decobert M, Cudennec A, Voltz C, Boulay D, Terranova JP, Stemmelin J, Roger P, Marabout B, Sevrin M, Vig\u00e9 X, Biton B, Steinberg R, Fran\u00e7on D, Alonso R, Avenet P, Oury-Donat F, Perrault G, Griebel G, George P, Soubri\u00e9 P, Scatton B (2005) Neurochemical, electrophysiological and pharmacological profiles of the selective inhibitor of the glycine transporter-1 SSR504734, a potential new type of antipsychotic. Neuropsychopharmacology 30:1963\u20131985","journal-title":"Neuropsychopharmacology"},{"key":"2196_CR10","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.eplepsyres.2007.04.008","volume":"75","author":"E Donato Di Paola","year":"2007","unstructured":"Donato Di Paola E, Gareri P, Davoli A, Gratteri S, Scicchitano F, Naccari C, De Sarro G (2007) Influence of levetiracetam on the anticonvulsant efficacy of conventional antiepileptic drugs against audiogenic seizures in DBA\/2 mice. Epilepsy Res 75:112\u2013121","journal-title":"Epilepsy Res"},{"key":"2196_CR11","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.heares.2005.11.006","volume":"212","author":"M Drayton","year":"2006","unstructured":"Drayton M, Noben-Trauth K (2006) Mapping quantitative trait loci for hearing loss in Black Swiss mice. Hear Res 212:128\u2013139","journal-title":"Hear Res"},{"key":"2196_CR12","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0378-5955(93)90207-H","volume":"65","author":"LC Erway","year":"1993","unstructured":"Erway LC, Willott JF, Archer JR, Harrison DE (1993) Genetics of age-related hearing loss in mice: I. Inbred and F1 hybrid strains. Hear Res 65:125\u2013133","journal-title":"Hear Res"},{"key":"2196_CR13","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s00213-006-0658-y","volume":"191","author":"K Fejgin","year":"2007","unstructured":"Fejgin K, Safonov S, P\u00e5lsson E, Wass C, Engel JA, Svensson L, Klamer D (2007) The atypical antipsychotic, aripiprazole, blocks phencyclidine-induced disruption of prepulse inhibition in mice. Psychopharmacology 191:377\u2013385","journal-title":"Psychopharmacology"},{"key":"2196_CR14","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0165-0173(89)90003-9","volume":"14","author":"RS Fisher","year":"1989","unstructured":"Fisher RS (1989) Animal models of the epilepsies. Brain Res Rev 14:245\u2013278","journal-title":"Brain Res Rev"},{"key":"2196_CR15","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s00213-007-0894-9","volume":"195","author":"DG Flood","year":"2007","unstructured":"Flood DG, Gasior M, Marino MJ (2007) Variables affecting prepulse inhibition of the startle reflex and the response to antipsychotics in DBA\/2NCrl mice. Psychopharmacology 195:203\u2013211","journal-title":"Psychopharmacology"},{"key":"2196_CR16","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s00213-009-1547-y","volume":"205","author":"DG Flood","year":"2009","unstructured":"Flood DG, Choinski M, Marino MJ, Gasior M (2009) Mood stabilizers increase prepulse inhibition in DBA\/2NCrl mice. Psychopharmacology 205:369\u2013377","journal-title":"Psychopharmacology"},{"key":"2196_CR17","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1124\/jpet.104.078402","volume":"313","author":"GB Fox","year":"2005","unstructured":"Fox GB, Esbenshade TA, Pan JB, Radek RJ, Krueger KM, Yao BB, Browman KE, Buckley MJ, Ballard ME, Komater VA, Miner H, Zhang M, Faghih R, Rueter LE, Bitner RS, Drescher KU, Wetter J, Marsh K, Lemaire M, Porsolt RD, Bennani YL, Sullivan JP, Cowart MD, Decker MW, Hancock AA (2005) Pharmacological properties of ABT-239 [4-(2-{2-[(2R)-2-methylpyrrolidinyl]ethyl}-benzofuran-5-yl)benzonitrile]: II. neurophysiological characterization and broad preclinical efficacy in cognition and schizophrenia of a potent and selective histamine H3 receptor antagonist. J Pharmacol Exp Ther 313:176\u2013190","journal-title":"J Pharmacol Exp Ther"},{"key":"2196_CR18","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1503\/cmaj.1041064","volume":"172","author":"DM Gardner","year":"2005","unstructured":"Gardner DM, Baldessarini RJ, Waraich P (2005) Modern antipsychotic drugs: a critical review. CMAJ 172:1703\u20131711","journal-title":"CMAJ"},{"key":"2196_CR19","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s002130100811","volume":"156","author":"MA Geyer","year":"2001","unstructured":"Geyer MA, Krebs-Thomson K, Braff DL, Swerdlow NR (2001) Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review. Psychopharmacology 156:117\u2013154","journal-title":"Psychopharmacology"},{"key":"2196_CR20","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1038\/sj.mp.4001159","volume":"7","author":"MA Geyer","year":"2002","unstructured":"Geyer MA, McIlwain KL, Paylor R (2002) Mouse genetic models for prepulse inhibition: an early review. Molec Psychiatry 7:1039\u20131053","journal-title":"Molec Psychiatry"},{"key":"2196_CR21","doi-asserted-by":"crossref","first-page":"7586","DOI":"10.1523\/JNEUROSCI.23-20-07586.2003","volume":"23","author":"GG Kinney","year":"2003","unstructured":"Kinney GG, Sur C, Burno M, Mallorga PJ, Williams JB, Figueroa DJ, Wittmann M, Lemaire W, Conn PJ (2003) The glycine transporter type 1 inhibitor N-[3-(4\u2032-fluorophenyl)-3-(4\u2032-phenylphenoxy)propyl]sarcosine potentiates NMDA receptor-mediated responses in vivo and produces an antipsychotic profile in rodent behavior. J Neurosci 23:7586\u20137591","journal-title":"J Neurosci"},{"key":"2196_CR22","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/j.bcp.2010.07.004","volume":"80","author":"K Kopec","year":"2010","unstructured":"Kopec K, Flood DG, Gasior M, McKenna BA, Zuvich E, Schreiber J, Salvino JM, Durkin JT, Ator MA, Marino MJ (2010) Glycine transporter (GlyT1) inhibitors with reduced residence time increase prepulse inhibition without inducing hyperlocomotion in DBA\/2 mice. Biochem Pharmacol 80:1407\u20131417","journal-title":"Biochem Pharmacol"},{"key":"2196_CR23","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1001\/archpsyc.62.11.1196","volume":"62","author":"H-Y Lane","year":"2005","unstructured":"Lane H-Y, Chang Y-C, Liu Y-C, Chiu C-C, Tsai GE (2005) Sarcosine or d-serine add-on treatment for acute exacerbation of schizophrenia. A randomized, double-blind, placebo-controlled study. Arch Gen Psychiatry 62:1196\u20131204","journal-title":"Arch Gen Psychiatry"},{"key":"2196_CR24","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.bcp.2007.01.023","volume":"73","author":"X Ligneau","year":"2007","unstructured":"Ligneau X, Landais L, Perrin D, Piriou J, Uguen M, Denis E, Robert P, Parmentier R, Anaclet C, Lin J-S, Burban A, Arrang J-M, Schwartz J-C (2007) Brain histamine and schizophrenia: potential therapeutic applications of H3-receptor inverse agonists studied with BF2.649. Biochem Pharmacol 73:1215\u20131224","journal-title":"Biochem Pharmacol"},{"key":"2196_CR25","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1021\/cn100017a","volume":"1","author":"C Lindsley","year":"2010","unstructured":"Lindsley C (2010) GlyT1\u2014up from the ashes. The importance of not condemning a mechanism based on a single chemotype. ACS Chem Neurosci 1:165\u2013166","journal-title":"ACS Chem Neurosci"},{"key":"2196_CR26","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1002\/cmdc.200600097","volume":"1","author":"CW Lindsley","year":"2006","unstructured":"Lindsley CW, Zhao Z, Leister WH, O\u2019Brien J, Lemaire W, Williams DL Jr, Chen T-B, Chang RSL, Burno M, Jacobson MA, Sur C, Kinney GG, Pettibone DJ, Tiller PR, Smith S, Tsou NN, Duggan ME, Conn PJ, Hartman GD (2006) Design, synthesis, and in vivo efficacy of glycine transporter-1 (GlyT1) inhibitors derived from a series of [4-phenyl-1-(propylsulfonyl)piperidin-4-yl]methyl benzamides. Chem Med Chem 1:807\u2013811","journal-title":"Chem Med Chem"},{"key":"2196_CR27","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s00213-005-2210-x","volume":"179","author":"T Lipina","year":"2005","unstructured":"Lipina T, Labrie V, Weiner I, Roder J (2005) Modulators of the glycine site on NMDA receptors, d-serine and ALX 5407, display similar beneficial effects to clozapine in mouse models of schizophrenia. Psychopharmacology 179:54\u201367","journal-title":"Psychopharmacology"},{"key":"2196_CR28","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1124\/jpet.106.106989","volume":"320","author":"KL Marquis","year":"2007","unstructured":"Marquis KL, Sabb AL, Logue SF, Brennan JA, Piesla MJ, Comery TA, Grauer SM, Ashby CR Jr, Nguyen HQ, Dawson LA, Barrett JE, Stack G, Meltzer HY, Harrison BL, Rosenzweig-Lipson S (2007) WAY-163909 [(7bR, 10aR)-1, 2, 3, 4, 8, 9, 10, 10a-octahydro-7bH-cyclopenta-[b][1,4]diazepino[6,7,1hi]indole]: a novel 5-hydroxytryptamine 2C receptor-selective agonist with preclinical antipsychotic-like activity. J Pharmacol Exp Ther 320:486\u2013496","journal-title":"J Pharmacol Exp Ther"},{"key":"2196_CR29","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s002130050434","volume":"134","author":"J McCaughran Jr","year":"1997","unstructured":"McCaughran J Jr, Mahjubi E, Decena E, Hitzemann R (1997) Genetics, haloperidol-induced catalepsy and haloperidol-induced changes in acoustic startle and prepulse inhibition. Psychopharmacology 134:131\u2013139","journal-title":"Psychopharmacology"},{"key":"2196_CR30","doi-asserted-by":"crossref","first-page":"10088","DOI":"10.1523\/JNEUROSCI.22-23-10088.2002","volume":"22","author":"H Misawa","year":"2002","unstructured":"Misawa H, Sherr EH, Lee DJ, Chetkovich DM, Tan A, Schreiner CE, Bredt DS (2002) Identification of a monogenic locus (jams1) causing juvenile audiogenic seizures in mice. J Neurosci 22:10088\u201310093","journal-title":"J Neurosci"},{"key":"2196_CR31","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/cne.11011","volume":"469","author":"KK Ohlemiller","year":"2004","unstructured":"Ohlemiller KK, Gagnon PM (2004) Cellular correlates of progressive hearing loss in 129S6\/SvEv mice. J Comp Neurol 469:377\u2013390","journal-title":"J Comp Neurol"},{"key":"2196_CR32","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/s002130100828","volume":"156","author":"B Olivier","year":"2001","unstructured":"Olivier B, Leahy C, Mullen T, Paylor R, Groppi VE, Sarnyai Z, Brunner D (2001) The DBA\/2J strain and prepulse inhibition of startle: a model system to test antipsychotics? Psychopharmacology 156:284\u2013290","journal-title":"Psychopharmacology"},{"key":"2196_CR33","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s002130100763","volume":"156","author":"A-M Ouagazzal","year":"2001","unstructured":"Ouagazzal A-M, Jenck F, Moreau J-L (2001) Drug-induced potentiation of prepulse inhibition of acoustic startle reflex in mice: a model for detecting antipsychotic activity? Psychopharmacology 156:273\u2013283","journal-title":"Psychopharmacology"},{"key":"2196_CR34","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.bbr.2006.05.018","volume":"172","author":"A-M Ouagazzal","year":"2006","unstructured":"Ouagazzal A-M, Reiss D, Romand R (2006) Effects of age-related hearing loss on startle reflex and prepulse inhibition in mice on pure and mixed C57BL and 129 genetic background. Behav Brain Res 172:307\u2013315","journal-title":"Behav Brain Res"},{"key":"2196_CR35","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s002130050333","volume":"132","author":"R Paylor","year":"1997","unstructured":"Paylor R, Crawley JN (1997) Inbred strain differences in prepulse inhibition of the mouse startle response. Psychopharmacology 132:169\u2013180","journal-title":"Psychopharmacology"},{"key":"2196_CR36","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/S0006-3223(01)01184-2","volume":"50","author":"W Perry","year":"2001","unstructured":"Perry W, Minassian A, Feifel D, Braff DL (2001) Sensorimotor gating deficits in bipolar disorder patients with acute psychotic mania. Biol Psychiatry 50:418\u2013424","journal-title":"Biol Psychiatry"},{"key":"2196_CR37","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.biopsych.2005.09.025","volume":"61","author":"W Perry","year":"2007","unstructured":"Perry W, Minassian A, Lopez B, Maron L, Lincoln A (2007) Sensorimotor gating deficits in adults with autism. Biol Psychiatry 61:482\u2013486","journal-title":"Biol Psychiatry"},{"key":"2196_CR38","doi-asserted-by":"crossref","first-page":"4603","DOI":"10.1021\/jm100210p","volume":"53","author":"E Pinard","year":"2010","unstructured":"Pinard E, Alanine A, Alberati D, Bender M, Borroni E, Bourdeaux P, Brom V, Burner S, Fischer H, Hainzl D, Halm R, Hauser N, Jolidon S, Lengyel J, Marty H-P, Meyer T, Moreau J-L, Mory R, Narquizian R, Nettekoven M, Norcross RD, Puellmann B, Schmid P, Schmitt S, Stalder H, Wermuth R, Wettstein JG, Zimmerli D (2010) Selective GlyT1 inhibitors: discovery of [4-(3-fluro-5-trifluoromethylpyridin-2-yl)piperazin-1-yl]-[5-methanesulfonyl-2-((S)-2, 2, 2-trifluoro-1-methylethoxy)phenyl]methanone (RG1678), a promising novel medicine to treat schizophrenia. J Med Chem 53:4603\u20134614","journal-title":"J Med Chem"},{"key":"2196_CR39","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1007\/s00213-006-0511-3","volume":"191","author":"RJ Ralph","year":"2007","unstructured":"Ralph RJ, Caine SB (2007) Effects of selective dopamine D1-like and D2-like agonists on prepulse inhibition of startle in inbred C3H\/H3J, SPRET\/EiJ, and CAST\/EiJ mice. Psychopharmacology 191:731\u2013739","journal-title":"Psychopharmacology"},{"key":"2196_CR40","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0091-3057(00)00310-5","volume":"67","author":"FO Risinger","year":"2000","unstructured":"Risinger FO, Cunningham CL (2000) DBA\/2J mice develop stronger lithium chloride-induced conditioned taste and place aversions than C57BL\/6J mice. Pharmacol Biochem Behav 67:17\u201324","journal-title":"Pharmacol Biochem Behav"},{"key":"2196_CR41","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/nrd1346","volume":"3","author":"BL Roth","year":"2004","unstructured":"Roth BL, Sheffler DJ, Kroeze WK (2004) Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia. Nat Rev Drug Discov 3:353\u2013359","journal-title":"Nat Rev Drug Discov"},{"key":"2196_CR42","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/s00213-001-0927-8","volume":"159","author":"R Schreiber","year":"2002","unstructured":"Schreiber R, Dalmus M, De Vry J (2002) Effects of \u03b14\/\u03b22- and \u03b17-nicotine acetylcholine receptor agonists on prepulse inhibition of the acoustic startle response in rats and mice. Psychopharmacology 159:248\u2013257","journal-title":"Psychopharmacology"},{"key":"2196_CR43","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s00213-009-1568-6","volume":"206","author":"P Singer","year":"2009","unstructured":"Singer P, Feldon J, Yee BK (2009) Are DBA\/2 mice associated with schizophrenia-like endophenotypes? A behavioural contrast with C57BL\/6 mice. Psychopharmacology 206:677\u2013698","journal-title":"Psychopharmacology"},{"key":"2196_CR44","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s00213-008-1072-4","volume":"199","author":"NR Swerdlow","year":"2008","unstructured":"Swerdlow NR, Weber M, Qu Y, Light GA, Braff DL (2008) Realistic expectations of prepulse inhibition in translational models for schizophrenia research. Psychopharmacology 199:331\u2013388","journal-title":"Psychopharmacology"},{"key":"2196_CR45","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.biopsych.2003.09.012","volume":"55","author":"G Tsai","year":"2004","unstructured":"Tsai G, Lane H-Y, Yang P, Chong M-Y, Lange N (2004) Glycine transporter 1 inhibitor, N-methylglycine (sarcosine), added to antipsychotics for the treatment of schizophrenia. Biol Psychiatry 55:452\u2013456","journal-title":"Biol Psychiatry"},{"key":"2196_CR46","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1037\/0735-7044.117.4.716","volume":"117","author":"JF Willott","year":"2003","unstructured":"Willott JF, Tanner L, O\u2019Steen J, Johnson KR, Bogue MA, Gagnon L (2003) Acoustic startle and prepulse inhibition in 40 inbred strains of mice. Behav Neurosci 117:716\u2013727","journal-title":"Behav Neurosci"},{"key":"2196_CR47","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S0378-5955(99)00003-9","volume":"130","author":"QY Zheng","year":"1999","unstructured":"Zheng QY, Johnson KR, Erway LC (1999) Assessment of hearing in 80 inbred strains of mice by ABR threshold analyses. Hear Res 130:94\u2013107","journal-title":"Hear Res"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-011-2196-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-011-2196-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-011-2196-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,8]],"date-time":"2019-06-08T07:21:20Z","timestamp":1559978480000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-011-2196-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2,8]]},"references-count":47,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["2196"],"URL":"https:\/\/doi.org\/10.1007\/s00213-011-2196-5","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,2,8]]}}}